FDA Wants to Oversee Lab Tests It Says Put Patients ‘At Risk’
The Food and Drug Administration said on Friday that it was moving to close what has widely been viewed as a loophole allowing certain lab tests — like those that determine the profile of a tumor or the genetic health of a fetus — to bypass review with virtually no tracking or oversight. The agency…